These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1450 related articles for article (PubMed ID: 17306477)

  • 1. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.
    Karavas E; Georgarakis E; Bikiaris D
    Eur J Pharm Biopharm; 2006 Aug; 64(1):115-26. PubMed ID: 16675210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer mobilization and drug release during tablet swelling. A 1H NMR and NMR microimaging study.
    Dahlberg C; Fureby A; Schuleit M; Dvinskikh SV; Furó I
    J Control Release; 2007 Sep; 122(2):199-205. PubMed ID: 17706829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
    Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers: effect of HPMC of different viscosity grades.
    Escudero JJ; Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2008 Mar; 351(1-2):61-73. PubMed ID: 17996408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
    Baviskar D; Sharma R; Jain D
    Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
    Li FQ; Hu JH
    Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets.
    Tajarobi F; Abrahmsén-Alami S; Carlsson AS; Larsson A
    Eur J Pharm Sci; 2009 May; 37(2):89-97. PubMed ID: 19429415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets.
    Viridén A; Wittgren B; Larsson A
    Eur J Pharm Sci; 2009 Feb; 36(2-3):297-309. PubMed ID: 19038336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer.
    Karavas E; Georgarakis E; Bikiaris D
    Int J Pharm; 2006 Apr; 313(1-2):189-97. PubMed ID: 16483734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.
    Chakraborty S; Khandai M; Sharma A; Patra ChN; Patro VJ; Sen KK
    Acta Pharm; 2009 Sep; 59(3):313-23. PubMed ID: 19819827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing HPMC matrices with improved resistance to dissolved sugar.
    Williams HD; Ward R; Culy A; Hardy IJ; Melia CD
    Int J Pharm; 2010 Nov; 401(1-2):51-9. PubMed ID: 20858538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
    Fuertes I; Miranda A; Millán M; Caraballo I
    Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
    Vostalová L; Rabisková M; Medvecká G
    Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.